The influence of dose on the long-term control of Classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The influence of dose on the long-term control of Classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy.

Int J Radiat Oncol Biol Phys. 1988 Nov;15(5):1141-6. Unique Identifier : AIDSLINE MED/89033232
Cooper JS; Division of Radiation Oncology, NYU Medical Center, N.Y. 10016.

Abstract: Between 1972 and 1985, 82 Classic Kaposi's Sarcomas were treated by radiotherapy in the Division of Radiation Oncology at NYU Medical Center. Doses ranged from 650 cGy in 1 fraction to 3,500 cGy in 10 fractions, reflecting the judgement of the responsible physician. A correlation was observed between the treatment given and the likelihood of long-term response. Doses of 2750 cGy or more delivered in 10 fractions over 2 weeks, or their equivalent, were associated with significantly better long-term local control. We therefore conclude that doses of this magnitude are appropriate for the long-term care of Classic Kaposi's sarcoma.
Keywords: Aged Aged, 80 and over Dose-Response Relationship, Radiation Female Follow-Up Studies Human Male Middle Age Radiotherapy Dosage Sarcoma, Kaposi's/*RADIOTHERAPY Skin Neoplasms/*RADIOTHERAPY Time Factors JOURNAL ARTICLE

KWDagedaged,80andoverdose-responserelationship,radiationfemalefollow-upstudieshumanmalemiddleageradiotherapydosagesarcoma,kaposi's/KWDradiotherapyskinneoplasms/KWDradiotherapytimefactorsjournalarticle
890228
M8920435

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .